Name: UMIN ID:
Unique ID issued by UMIN | UMIN000005218 |
---|---|
Receipt number | R000006192 |
Scientific Title | A phase I/II study of combination therapy with S-1/ CPT-11 plus Panitumumab as second line therapy in metastatic colorectal cancer patients with KRAS wild type |
Date of disclosure of the study information | 2011/03/09 |
Last modified on | 2019/05/23 16:02:10 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2011/03/08 13:44:38 | ||
2 | Update | 2019/05/23 15:58:02 | Recruitment status Date of IRB Last follow-up date |
|
3 | Update | 2019/05/23 16:00:51 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code TEL Last name of contact person Zip code TEL Name of primary person or sponsor Organization Post marketing survey by drug manufacture etc., specified by Japanese law. Address2 Tel2 Email2 Address3 Tel3 Email3 Organization Organization Address Address Tel |
|
4 | Update | 2019/05/23 16:02:10 | URL releasing protocol URL related to results and publications Number of participants that the trial has enrolled Results Results Results date posted Baseline Characteristics Baseline Characteristics Participant flow Participant flow Adverse events Adverse events Outcome measures Outcome measures |